AIM ImmunoTech Inc.
Research AIM ImmunoTech Inc. (AIM@XASE) on Bullrun: market cap USD 6.82M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAIM@XASE
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 6.82M
- Financial periodQ1 2026
- RevenueUSD 22.00K
- Net income-USD 3.02M
- Free cash flow-USD 2.75M
- Gross margin81.8%
Valuation Snapshot
latest market cap is USD 6.82M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 88.00K | -USD 13.96M | -USD 11.34M | -45.5% | n/a | USD 2.99M | USD 4.90M | -USD 9.78M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | USD 6.82M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 USD.
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is AIM ImmunoTech Inc.'s market cap?
AIM ImmunoTech Inc.'s market capitalization is USD 6.82M.
What does AIM ImmunoTech Inc. do?
AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts.